Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

UK urges medicine suppliers to stockpile before Brexit transition ends

Published 08/03/2020, 12:54 PM
Updated 08/03/2020, 01:00 PM
© Reuters. Illustration photo shows various medicine pills in their original packaging in Brussels

LONDON (Reuters) - The British government has urged medicine suppliers to prepare for the country's exit from the EU single market and customs union on Dec. 31 by building up six weeks' worth of stocks in case of disruption to imports.

Under the terms of an ongoing transition period, customs and border arrangements have remained unchanged since Britain left the European Union on Jan. 31, but new checks are expected to come into force when the transition ends on Dec. 31.

"We recognise that global supply chains are under significant pressure, exacerbated by recent events with COVID-19," the health ministry said in a letter to medicine suppliers which it published on Monday.

"However, we encourage companies to make stockpiling a key part of contingency plans, and ask industry, where possible, to stockpile to a target level of six weeks' total stock on UK soil."

Britain and the EU are negotiating the terms of a new free trade agreement, but it is not clear whether a deal will be agreed and implemented before the Dec. 31 deadline, reviving fears of a disruptive "hard Brexit".

The government letter outlined the multiple pressures that the National Health Service (NHS) would be facing by winter.

"The ongoing pandemic, gradual resumption of NHS activity, and seasonal pressures, mean we must prepare thoroughly for the end of the transition period," it said.

To ensure continuity of patient care, medicine suppliers should prepare to reroute freight away from potential disruption points, especially the crossings between Dover (NYSE:DOV) and Folkestone on the English side and Calais, Coquelles and Dunkirk in France.

"Companies are encouraged to review their own logistics arrangements and consider making plans for avoiding the short straits as a matter of priority," the letter said.

The health ministry stood ready to support companies with their plans if needed.

The ministry said it had built up a centralised stock of fast-moving medical devices and clinical consumables in the run-up to the exit from the EU on Jan. 31.

© Reuters. Illustration photo shows various medicine pills in their original packaging in Brussels

"Some of this stock remains and accounting for likely demand trends for the time of year, we plan to build these levels back up to a target level of six weeks' total stock," it said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.